Cabergoline
NDC 69238-2693, Cabergoline, tablet, from Amneal Pharmaceuticals NY LLC.
- Product NDC
- 69238-2693
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals NY LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218618
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69238-2693 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CABERGOLINE.5 mg/1
Pharmacologic classes
Ergolines [CS]; Ergot Derivative [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69238-2693-1 | 69238269301 | 8 TABLET in 1 BOTTLE (69238-2693-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a246b015-e19c-4b4f-9089-aea1108687baMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=69238-2693NADAC price for package 69238269301
GET /v1/drugs/nadac/69238269301
Use it
Look up 69238-2693 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69238-2693 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69238-2693. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.